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Introduction
The increase of  bacterial resistance specifically leading to 
treatment failures is directly responsiblefor the current 
increase in morbidity and mortality associated with 
bacterial infections1. Among the known mechanisms 
of  resistance, active efflux via resistance-nodulation-cell 
division (RND) pumps is one of  the most occurring 
systems in Gram-negative bacteria2. This efflux system 
depends on membrane energy and efficiently expels 
structurally unrelated antibiotic molecules across the 
bacterial envelope via a tripartite complex (comprising 
an inner membrane pump, a periplasmic fusion protein, 
and an outer membrane channel)3. Today, the increase 
of  resistance to antibiotics propels the search of  new 
drugs to 
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combat resistant microorganisms. Therefore, species 
commonly used as herbal medicine appear biologically 
active components isolated from plant as a good 
alternative, due to the variety of  plants secondary 
metabolites and their potential to exert antimicrobial 
activities4-6. In Cameroon, several medicinal plants are 
used as herbal medicines to treat infectious diseases4. 
The present work was therefore designed to investigate 
the antibacterial potential of  some commonly used 
medicinal plants namely  Entada abyssinica Steud., Entada 
africana Guill. & Perr., Pentaclethra macrophylla Benth. 
(Fabaceae),  Allexis cauliflora (Oliv.) Pierre. (Violaceae), 
Anthocleista leibrechtsiana de Wild et Th.  (Gentianaceae), 
Carapa procera DC. (Meliaceae), Carica papaya L. 
(Caricaceae) and  Persea Americana Mill. (Lauraceae) 
against Gram-negative bacteria including MDR 
phenotypes.
Material and methods
Plant Materials and Extraction
The plant materials used in this work were collected in 
different regions of  Cameroon and included the leaves 
and roots  of   Entada  abyssinica collected at Nde divi-
sion, West Region in December 2012; the bark of  En-
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Abstract
Background:  Medicinal plants are used worldwide for several human ailments including bacterial infections. The present 
work was designed to assess the in vitro antibacterial activities of  some Cameroonian medicinal plants including Entada 
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Enterobacter aerogenes,  Klebsiella  pneumoniae and Providencia stuartii. 
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ranges of  64 to 1024 µg/mL. The most active extract was that from Pentaclethra macrophylla (TPM) that showed inhibitory 
activities against five of  the eight (62.5%) tested bacteria. The lowest MIC value (64 μg/mL) was recorded with the crude 
extract of  Entada africana against E. coli AG100A whilst the best MBC (256 µg/mL) value was also obtained with methanol 
extract of   Persea americana against this bacterial strain.
Conclusion: The results of  the present work provide baseline information on the possible use of  Pentaclethra macrophylla, 
Entada africana and Entada abyssinica in the treatment of  selected bacterial infections. 
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tada africana collected at Far Nord Region in February 
2011; the bark of  Pentaclethra macrophylla collected in 
November 2012 at Mfou division (Centre Region); the 
leaves of Allexis cauliflora and the bark of  Carapa procera 
collected in August 2012 at Monkey mount, kribi divi-
sion (South Region), Anthocleista leibrechtsiana collected 
in November 2012 in June 2012 at Pouma division (Lit-
toral Region), the seeds of  Carica papaya and stones of  
Persea americana collected in  February 2013 at Mfoundi 
market (Centre Region). The botanical identification of  
these plants was done at the Cameroon National Her-
barium in Yaounde by Mr Victor Nana, where voucher 
specimens were kept (Table 1). The powdered air-dried 
(under shade) sample from Allexis cauliflora, Anthocleis-
ta leibrechtsiana, Carapa procera, Carica papaya and Persea 
americana were extracted with methanol, that of Entada 
africana with the solvent mixture CH2Cl2/MeOH (1:1), 
those of  Entada abyssinica with ethyl acetate and that of 
Pentaclethra macrophylla with CH2Cl2/MeOH (1:1) for 48 
h at room temperature. The extract was then concen-
trated under reduced pressure under vacuum to give a 
residue that constituted the crude extract. They were 
then kept under 40C until use.
Table 1. Plants used in the present study and evidence of  their antimicrobial activities.
Plants samples 
and herbarium voucher 
numbera 
Traditional used part 
used 
Known antimicrobial activities of  plant extracts or 
compounds
Fabaceae 
Entada abyssinica  
26967 SRF/ CAM
Coughs, fever, rheumatic, abdominal
 pains, and diarrhea, prevent miscarriage 
7, 8, 
gonorrhea9,  Bronchite, eyes 
inflammation10, 
snake bite11,   sleeping sickness12. 
Leaves 
and roots 
Antimicrobial activities of   methanol extracts, fractions  
and Compounds (5S,6R,8aR)-5-(carboxymethyl)-3,4,4a,5,6,7
,8,8a-octahydro-5,6,8a- trimethylnaphthalenecarboxylic acid, 
methyl 3,4,5-trihydroxybenzoate, benzene-1,2,3-triol and 2,3-
dihydroxypropyltriacontanoate; M and S: Ef, Sau, Kp, St, 
Pm, 




Abortive, stimulating  agent  and  tonic, 
antidote,  healing and fever-reducing 
beverages tonic,  stomach ache, wound  
dressing, preventing suppuration14.
.bark. Ethanol extracts ¶



















Wound infections19. bark Antibacterial activities of  ethanol extracts 




Typhoid   fever,  parasitic diseases21,  
hepatic affections, dyspepsia,  colic ,  
gastric  ulcer22, toothache23, analgesic, 
amebicide, antibacterial, febrifuge, 
hypotensive, laxative24.
..seeds.... Antimicrobial activities of  aqueous and ethanol extracts; ¶




Diarrhea, dysentery, toothache, intestinal 
parasites26,  hypertension,  cancer,  
menstrual  problems,  inflammation,  
wounds27;  
Stones Antimicrobial activities of   methanol, ethyl acetate and 
chloroform 
extracts W and Q:  Ec, K p, Bs, Sp, Pa, Sa, Cu, St, Ng, Ca28 .
 a(HNC): Cameroon National Herbarium; (SRF): Société des reserves forestière du Cameroun; b(-): Not reported. Screened activity: Significant (S:MIC < 100 µg/mL), 
moderate (M:100 < MIC≤ 625 µg/mL), Weak (W:MIC > 625 µg/mL)28, Q:qualitative activity based on the determination of  the  inhibition zone. Ca:Candida albicans; 
St:  Salmonella typhi;  An:Aspergilus nicfer;  Bs:Bacillus subtilis;  EC:Escherichia coli;  Kp:Klebsiella pneumoniae;  Pa:Pseudomonas aeruginosa;  Pvt:Proteus vulgaris;  Sau:  Staphylococcus 
aureus; Cn: Cryptococcus neoformans, Cu:  Candida utilis, Sc:  Saccharomyces cereviciae;Sm:Streptococcus mutans;  Sa:Streptococcus aeoginosa; La :Lactobacillus acidophillus;  ML:Micrococcus 
luteus; San:Streptococcus anginosus;  Ea:Enterobacter aerogenes;  Rs:Rhizoctonia solanic;  Bp:Bacillus punilus;  Sb:Shigella boydii;  Ss:Shigella sonnei;  Sd:Shigella dysenteria;  Vc:Vibrio cholerae; 
Csp:Citrobacter sp; Pm:Proteus mirabilis;Eag: Enterobacter agglomerans Ecl: Enterobacter cloacae Sal:Staphylococcus albus;  Sma:  Serratia marcescens;  Sp:  Schizosaccharomyces pombe; 
Ha:Hansenula anomala;  Scl:Sclerotinia libertiana; PC:Penicillim crustasum;  Mm:Mucor mucedo;  Rc:Rhizopus chinensis;Ecl:Enterobacter cloacae; PS:Providencia stuartii;  Pl:Paenibacillus 
larvae;  Vhs: Herpes simplex virus;Vp: Virus of  poliomyelitis;VI: Influenza virus; Mm: Morganella morganii Sd: Shigella dysenteriae; Pv: Proteus vulgaris, Cf: Citrobacter freundii,
Bacterial strains and culture media
The studied microorganisms included references 
(from the American Type Culture Collection) and 
clinical (Laboratory collection) strains of  Escherichia coli, 
Enterobacter aerogenes, Klebsiella pneumoniae, and Providencia 
stuartii (Table 2). They were maintained on agar slant at 
4◦C and sub-cultured on a fresh appropriate agar plates 
24 hrs prior to any antimicrobial test. Mueller Hinton 
Agar (MHA) was used for the activation of  bacteria for 
24 h prior to use and the Mueller Hinton Broth (MHB) 
was used for the MIC determinations.
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Table 2. Bacterial strains and features 
Bacteria Features References
Escherichia  coli
ATCC8739 Reference strain 
AG100A AG100ΔacrAB::KANR 29, 30 
Enterobacter aerugenes
ATCC13048 Reference strain
CM64 CHLR resistant variant obtained from ATCC13048




Kp55 Clinical MDR isolate, TETR ,AMPR ,ATMR , and CEFR 32
Providencia stuartii
ATCC29916 Reference strain
NAE16 Clinical MDR isolate, AcrAB-TolC 33
AMPR, ATMR, CEFR, CFTR, CHLR, FEPR, KANR, MOXR,  NALR, NORR STRR, and TETR Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, 
cefepime, kanamycin, moxalactam, streptomycin, and tetracycline; MDR: multidrug resistant.,  OMPF  and OMPC:  Outer Membrane Protein F and C respectively. AcrAB-
TolC : efflux pump AcrAB associate to TolC porine.
Bacterial susceptibility determinations
The respective MICs of  samples on the studied bacteria 
were determined by using rapid p-Iodonitrotetrazolium 
chloride (INT, Sigma-Aldrich, St. Quentin Fallavier, 
France) colorimetric assay34. Briefly, the test samples 
were first dissolved in dimethylsulfoxide (DMSO)/
MHB. The solution obtained was then added to MHB, 
and serially diluted two fold (in a 96-well microplate). 
One hundred microlitres (100 μL) of  inoculum (1.5 × 
106 CFU/mL) prepared in MHB was then added. The 
turbidity of  the microbial suspension was adjusted with 
a densitometer to a McFarland standard of  0.5 that is 
equivalent to 1-5 x 108 CFU/mL. The plates were cov-
ered with a sterile plate sealer, then agitated to mix the 
contents of  the wells using a shaker and incubated at 
37◦C for 18 hrs. The final concentration of  DMSO was 
set at 2.5% (a concentration at which DMSO does not 
affect the microbial growth). Wells containing MHB 
and 100 μl of  inoculums served as a negative control. 
Chloramphenicol (CHL) was used as reference antibi-
otic. The MICs of  samples were detected after 18 h of  
incubation at 37◦C, following addition (40 μL) of  0.2 
mg/mL INT and incubation at 37◦C for 30 min5. Vi-
able bacteria reduced the yellow dye to pink. MIC was 
defined as the lowest sample concentration that exhib-
ited complete inhibition of  microbial growth and then 
prevented this change MIC was defined as the lowest 
sample concentration that prevented this change and 
exhibited complete inhibition of  bacterial growth.  
For the determination of   MBC, the microplates were 
filled by 150 µL of  MHB without extract of  plant; for 
wells not having received a INT (during the reading of  the 
MIC), 50 µL of  the contents of  the wells corresponding 
to the concentrations higher or equal to the MIC was 
taken and introduced into these microplates. These 
were then incubated during 48 h à 370C, followed by 
revelation with the INT. All the concentrations among 
which we did not observe pink coloring were taken as 
bactericidal and the lowest was noted as MBC. 
Results
The data summarized in Table 3 shows the antibacte-
rial activities of  the tested strains. All extracts were ac-
tive on at least one of  the eight tested bacteria with the 
MIC values ranging from 64 to 1024 µg/mL. The most 
active extracts were those of   P. macrophylla (TPM),  E. 
africana (TM2), bark of  young from plant E. abyssinica 
(TM1’) and bark of  old plant from E. abyssinica (TM1) 
with the respective inhibitory activities recorded against 
62.5 %, 50%, 37.5% and 37.5%.  The lowest MIC value 
(64 μg/mL) was obtained with E. africana (TM2) extract 
against E. coli AG100A. This strain was the most sensi-
tive amongst the tested bacteria towards all the plant 
extracts whilst no activity was recorded against E. aeru-
genes CM64 at the tested concentrations. The MIC of  
chloramphenicol was lower compared to those of  the 
tested extract on all bacteria used in this study. However 
they were still high and varied from 8 to above 256 µg/
mL. This confirms the high level of  resistance of  stud-
ied bacterial strains. The extracts of  P. americana (AV), 
E. africana (TM2) and A. cauliflora (ACT) showed MBC 
values of  128; 256 and 512μg/mL respectively against 
Echerichia coli AG100A. 
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Discussion
Plants constitute a good source of  anti-infective agents 
and were found to be effective in the fight against mi-
crobial infections35. A number of  secondary metabo-
lites derived from plants such alkaloids, anthocyanins, 
anthraquinones, flavonoids, phenols, saponins, tannins, 
steroids and triterpenes have previously showed anti-
bacterial activities4,5,36. The extracts are considered to 
possess significant activity when they have MIC below 
100 μg/mL, moderate activity when their MICs vary be-
tween 100 and 625 μg/mL or weak activity their display 
MICs above 625 μg/mL4. Consequently, the activity of  
E. Africana (TM2) against E. coli AG100A (64 µg/mL) 
could be considered important. Nevertheless, the overall 
activity of  the studied plants could be considered as se-
lective and rather moderate or weak. To the best of  our 
knowledge, the in vitro antibacterial activity of  P. macro-
phylla is being reported for the first time. Nevertheless, 
the aqueous and ethanol leaf  extracts of  this plant were 
previously tested for their anti-diarrheal activity using 
experimental animal models. Diarrheal infections are 
also caused by pathogenic bacteria such as E. coli and 
other enterobacteriaceae. Besides, it was demonstrated 
several tannins, alkaloids, saponins, flavonoids, steroids 
and or terpenoids have antibacterial activities37. 
Further detection of  this class of  chemical in this extracts 
will therefore provide better understanding on its anti-
bacterial potential. The antimicrobial activities of  plants 
of  the genus Entada have also been demonstrated13,15. 
Teke and al.13 demonstrated that the methanol extract, 
fractions and compounds from the stem bark of  E. 
abyssinica have moderate activities against bacteria and 
fungi. The weak activity observed in this work is there-
fore consistent with their studies. The weak antibacte-
rial activities of  the methanol extract of  E. abyssinica 
stem bark have also been reported38, validating the low 
inhibitory potential of  the plant as documented herein. 
The presence of  alkaloids, flavonoids, tannins, saponins 
and cardiac glycosides have been reported in E. abyssi-
nica and E. africana13,39. 
The activities recorded in this study may be due to the 
presence of  such chemical classes chemicals in the 
tested extracts.  Although the activity recorded with the 
methanol extract of P. americana was found weak, this 
plant is known to possess antimicrobial activities against 
sensitive bacteria and fungi28. The result of  antibacte-
rial activity obtained with the extract of  the seeds of  
C. papaya is in accordance with those obtain by Ogun-
jobi and Ogunjobi25 who previously demonstrated the 
antibacterial activity of  ethanol and aqueous extract of  
the seeds of  C. papaya on the various bacteria stains. 
Ogunjobi and Ogunjobi25 also revealed showed that the 
seeds of  this plant contain  reducing sugars, phenols, 
alkaloids and tannins which could be responsible for 
the inhibitory activities of  this plant as observed against 
K. pneumoniae  ATCC11296 and P. stuarti NAE16. The 
antibacterial activity of  the ethanol extract of  C. procera 
has also been demonstrated against S. aureus, E. coli, and 
P. aeruginosa strains20. The present study therefore brings 
additional information on the antibacterial activities of  
this plant against multi-resistant bacteria. To the best of  
African Health sciences Vol 14 No. 1 March 2014




Tested samples, MIC and MBC (in bracket)




















- - - - 1024(-) 16(128)
Klebsiella 
- - - - - 1024(-) 1024(-) 1024(-) 512(-) 1024(-) 16(256-)
KP55 - - - - - 512(1024) - 128(512) - 32(1024)
- - - - - - 512(-) - 1024(-) 256(-) 8(128)
CM64 - - - - - - - - - - - >256(-)
- 1024 
(-)
- - - 1024(-) - - 1024(-) 32(1024)
NAE16 - - - 512(-) - - - - 32(1024)
(-):> 1024 µg/mL for the extracts; (in braket): MBC in µg/mL;  AV: P. Americana, TM2: E. Africana; T M1’: Young E. abyssinica, TM1: Old E. 
abyssinica, TPM:P. macrophylla, ACT: Al. cauliflora; ALD: A. leibrechtsiana, CPE: Carapa procera PAY: C. papaya, CHL: Chloramphenicol. (in bold): 
significant activity
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our knowledge, the antibacterial activities of  A. leibrech-
tsiana and A. cauliflora extracts are being reported here 
for the first time. The weak antibacterial activities of  
most of  the studied plants could be due to the resist-
ance features of  the studied bacterial strains. However, 
their effects on at least one bacterial species could jus-
tify their use in African traditional medicine in the treat-
ment of  microbial infections as reported in Table 1. 
Conclusions. 
The present work provides a supportive information of  
the antibacterial activities of  the tested medicinal plants 
and the possibility to use the extracts from Pentaclethra 
macrophylla, Entada africana, Entada abyssinica in the 
control of  selected bacterial infections. 
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